250 related articles for article (PubMed ID: 10509176)
1. Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?
Manji HK; Moore GJ; Chen G
Biol Psychiatry; 1999 Oct; 46(7):929-40. PubMed ID: 10509176
[TBL] [Abstract][Full Text] [Related]
2. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.
Manji HK; Moore GJ; Chen G
J Clin Psychiatry; 2000; 61 Suppl 9():82-96. PubMed ID: 10826666
[TBL] [Abstract][Full Text] [Related]
3. FGF-21, a novel metabolic regulator, has a robust neuroprotective role and is markedly elevated in neurons by mood stabilizers.
Leng Y; Wang Z; Tsai LK; Leeds P; Fessler EB; Wang J; Chuang DM
Mol Psychiatry; 2015 Feb; 20(2):215-23. PubMed ID: 24468826
[TBL] [Abstract][Full Text] [Related]
4. Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications.
Manji HK; Bebchuk JM; Moore GJ; Glitz D; Hasanat KA; Chen G
J Clin Psychiatry; 1999; 60 Suppl 2():27-39; discussion 40-1, 113-6. PubMed ID: 10073385
[TBL] [Abstract][Full Text] [Related]
5. Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilizers.
Manji HK; Moore GJ; Chen G
Br J Psychiatry Suppl; 2001 Jun; 41():s107-19. PubMed ID: 11450170
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms underlying mood stabilization in manic-depressive illness: the phenotype challenge.
Ikonomov OC; Manji HK
Am J Psychiatry; 1999 Oct; 156(10):1506-14. PubMed ID: 10518159
[TBL] [Abstract][Full Text] [Related]
7. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.
Chen G; Huang LD; Jiang YM; Manji HK
J Neurochem; 1999 Mar; 72(3):1327-30. PubMed ID: 10037507
[TBL] [Abstract][Full Text] [Related]
8. Lithium down-regulates tau in cultured cortical neurons: a possible mechanism of neuroprotection.
Rametti A; Esclaire F; Yardin C; Cogné N; Terro F
Neurosci Lett; 2008 Mar; 434(1):93-8. PubMed ID: 18289787
[TBL] [Abstract][Full Text] [Related]
9. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS.
Chen G; Zeng WZ; Yuan PX; Huang LD; Jiang YM; Zhao ZH; Manji HK
J Neurochem; 1999 Feb; 72(2):879-82. PubMed ID: 9930766
[TBL] [Abstract][Full Text] [Related]
10. Lithium activates the c-Jun NH2-terminal kinases in vitro and in the CNS in vivo.
Yuan P; Chen G; Manji HK
J Neurochem; 1999 Dec; 73(6):2299-309. PubMed ID: 10582587
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotection by lithium and valproate varies between cell types and cellular stresses.
Lai JS; Zhao C; Warsh JJ; Li PP
Eur J Pharmacol; 2006 Jun; 539(1-2):18-26. PubMed ID: 16678157
[TBL] [Abstract][Full Text] [Related]
12. Lithium-induced activation of Akt and CaM kinase II contributes to its neuroprotective action in a rat microsphere embolism model.
Sasaki T; Han F; Shioda N; Moriguchi S; Kasahara J; Ishiguro K; Fukunaga K
Brain Res; 2006 Sep; 1108(1):98-106. PubMed ID: 16843447
[TBL] [Abstract][Full Text] [Related]
13. Lithium reduces tau phosphorylation: effects in living cells and in neurons at therapeutic concentrations.
Lovestone S; Davis DR; Webster MT; Kaech S; Brion JP; Matus A; Anderton BH
Biol Psychiatry; 1999 Apr; 45(8):995-1003. PubMed ID: 10386182
[TBL] [Abstract][Full Text] [Related]
14. Lithium neuroprotection: molecular mechanisms and clinical implications.
Rowe MK; Chuang DM
Expert Rev Mol Med; 2004 Oct; 6(21):1-18. PubMed ID: 15488156
[TBL] [Abstract][Full Text] [Related]
15. Kainate-induced toxicity in the hippocampus: potential role of lithium.
Crespo-Biel N; Camins A; Canudas AM; Pallàs M
Bipolar Disord; 2010 Jun; 12(4):425-36. PubMed ID: 20636640
[TBL] [Abstract][Full Text] [Related]
16. Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation.
Yazlovitskaya EM; Edwards E; Thotala D; Fu A; Osusky KL; Whetsell WO; Boone B; Shinohara ET; Hallahan DE
Cancer Res; 2006 Dec; 66(23):11179-86. PubMed ID: 17145862
[TBL] [Abstract][Full Text] [Related]
17. Lithium induces gene expression through lymphoid enhancer-binding factor/T-cell factor responsive element in rat PC12 cells.
Bettini E; Magnani E; Terstappen GC
Neurosci Lett; 2002 Jan; 317(1):50-2. PubMed ID: 11750994
[TBL] [Abstract][Full Text] [Related]
18. Cellular plasticity cascades: genes-to-behavior pathways in animal models of bipolar disorder.
Einat H; Manji HK
Biol Psychiatry; 2006 Jun; 59(12):1160-71. PubMed ID: 16457783
[TBL] [Abstract][Full Text] [Related]
19. High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.
Guttuso T
Med Hypotheses; 2019 Oct; 131():109302. PubMed ID: 31443765
[TBL] [Abstract][Full Text] [Related]
20. Lithium and synaptic plasticity.
Salinas PC; Hall AC
Bipolar Disord; 1999 Dec; 1(2):87-90. PubMed ID: 11252664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
